Andra AP fonden Buys New Stake in Celestica, Inc. $CLS

Andra AP fonden purchased a new position in Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS) in the 1st quarter, Holdings Channel.com reports. The firm purchased 22,500 shares of the technology company’s stock, valued at approximately $6,338,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC bought a new stake in Celestica in the fourth quarter valued at $28,000. Ascentis Independent Advisors bought a new position in shares of Celestica during the first quarter valued at $29,000. Swiss RE Ltd. acquired a new stake in shares of Celestica in the 4th quarter valued at $29,000. Cullen Frost Bankers Inc. bought a new stake in shares of Celestica in the 4th quarter worth about $30,000. Finally, Sittner & Nelson LLC acquired a new stake in shares of Celestica during the 4th quarter worth about $31,000. Institutional investors own 67.38% of the company’s stock.

Celestica Stock Performance

Shares of NYSE:CLS opened at $335.45 on Thursday. The company has a current ratio of 1.26, a quick ratio of 0.73 and a debt-to-equity ratio of 0.36. Celestica, Inc. has a 1-year low of $158.15 and a 1-year high of $474.02. The stock has a market capitalization of $38.57 billion, a P/E ratio of 40.56, a P/E/G ratio of 0.78 and a beta of 2.05. The business has a 50-day moving average price of $364.08 and a two-hundred day moving average price of $332.18.

Celestica (NYSE:CLSGet Free Report) (TSE:CLS) last issued its earnings results on Monday, April 27th. The technology company reported $2.16 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.08 by $0.08. Celestica had a net margin of 6.95% and a return on equity of 36.91%. The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same quarter last year, the firm earned $1.20 EPS. The company’s revenue for the quarter was up 52.8% on a year-over-year basis. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Equities analysts predict that Celestica, Inc. will post 9.57 earnings per share for the current year.

Insider Activity at Celestica

In other Celestica news, CEO Robert Mionis sold 66,056 shares of Celestica stock in a transaction on Monday, June 15th. The shares were sold at an average price of $400.06, for a total transaction of $26,426,363.36. Following the completion of the sale, the chief executive officer owned 134,328 shares of the company’s stock, valued at approximately $53,739,259.68. The trade was a 32.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Michael Max Wilson sold 4,168 shares of the company’s stock in a transaction on Tuesday, May 19th. The shares were sold at an average price of $333.31, for a total transaction of $1,389,236.08. Following the sale, the director owned 24,718 shares of the company’s stock, valued at $8,238,756.58. The trade was a 14.43% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 161,168 shares of company stock worth $63,190,485 over the last ninety days. Company insiders own 1.10% of the company’s stock.

Key Headlines Impacting Celestica

Here are the key news stories impacting Celestica this week:

Analysts Set New Price Targets

Several equities analysts recently issued reports on CLS shares. Royal Bank Of Canada lifted their price target on shares of Celestica from $400.00 to $440.00 and gave the company an “outperform” rating in a report on Wednesday, April 29th. UBS Group raised their price objective on shares of Celestica from $355.00 to $400.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. JPMorgan Chase & Co. lifted their target price on shares of Celestica from $410.00 to $425.00 and gave the company an “overweight” rating in a research note on Wednesday, April 29th. Citigroup boosted their target price on Celestica from $338.00 to $415.00 and gave the stock a “buy” rating in a report on Wednesday, April 29th. Finally, Weiss Ratings lowered Celestica from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Celestica currently has an average rating of “Buy” and a consensus price target of $427.42.

Read Our Latest Report on Celestica

Celestica Profile

(Free Report)

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.

See Also

Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLSFree Report) (TSE:CLS).

Institutional Ownership by Quarter for Celestica (NYSE:CLS)

Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.